Viking Therapeutics
VKTX
VKTX
6 hedge funds and large institutions have $252K invested in Viking Therapeutics in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Creative Planning
Overland Park,
Kansas
|
$18K |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$11K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$8K |
Top Sellers
| 1 |
VKH
1
Virtu KCG Holdings
New York
|
$0 |
| 2 |
2
Goldman Sachs
New York
|
$107K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Goldman Sachs
New York
| $107K | 18,262 | -5,432 | -23% |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $106K | 18,275 | – | – |
|
|
3
Creative Planning
Overland Park,
Kansas
| $18K | 3,000 | +3,000 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $11K | 1,903 | +1,597 | +522% |
|
|
5
UBS Group
Zurich,
Switzerland
| $8K | 1,408 | +1,408 | New |
|
|
BIM
6
BlackRock Investment Management
Wilmington,
Delaware
| $2K | 327 | – | – |
|
|
VKH
7
Virtu KCG Holdings
New York
| – | – | -11,403 | Closed |
|
8
Morgan Stanley
New York
| – | – | -16 | Closed |
|